This article aims to explore the epidemiology, aetiology and pathophysiology of laryngotracheobronchitis (croup), a commonly presenting illness faced by paramedics attending young children in the community. In this article, current evidence surrounding pharmacotherapies for croup shall be discussed with relevance to paramedic practice. Furthermore, current dosages, routes of administration, cost-effectiveness and weight-based drug calculations will be outlined and debated alongside the current evidence base.

To view this article

You cannot access this article because you do not have a valid subscription. Please use the options below to create a subscription. If you have any queries about your account please contact our subscriptions department or telephone free 0800 137201 (UK callers only) or +44 (0)1722 716997 for callers outside the UK.